ANNALS ACADEMY OF MEDICINE SINGAPORE is a reputable journal dedicated to the field of medicine, published by the Academy of Medicine, Singapore. With an E-ISSN of 2972-4066, this journal has been an influential platform since its inception in 1973, aiming to disseminate high-quality research and clinical findings pertinent to both local and international audiences. Currently ranked in the Q3 quartile in Medicine (miscellaneous), it holds a commendable 83rd percentile in Scopus rankings, indicating its significant academic contribution within the competitive landscape of medical literature. Although the journal operates on a traditional subscription-based model, it continues to provide access to critical insights that serve not only researchers but also healthcare professionals and students engaged in the ever-evolving medical sector. As it approaches its comprehensive publication mark in 2024, ANNALS will continue to focus on enhancing global healthcare discourse, making it an invaluable resource for those committed to advancing medical knowledge and practice.

Welcome to the Journal of Clinical and Diagnostic Research, a leading open-access journal published by the PREMCHAND SHANTIDEVI RESEARCH FOUNDATION since 2007. This journal serves as a crucial platform for researchers and professionals in the fields of biochemistry, genetics, and molecular biology, with a particular focus on clinical biochemistry. The journal is recognized for its commitment to disseminating high-quality research, fostering academic dialogue, and enabling practitioners to stay at the forefront of advancements in diagnostic methods. With an ISSN of 2249-782X, the journal enhances accessibility to critical research findings and discussions, ensuring that the scientific community and interested students can engage with valuable insights. Although coverage has been discontinued in Scopus since 2018, its rankings within the clinical biochemistry domain reflect a dedicated scholarly impact that continues to influence research trajectories. We invite you to explore the wealth of knowledge presented in the Journal of Clinical and Diagnostic Research and contribute to the evolving discourse in clinical science.

Multiple Sclerosis and Related Disorders, published by Elsevier Science Ltd, is a leading journal that serves as a vital resource in the field of neurology, particularly focused on multiple sclerosis and its associated conditions. This esteemed journal, which holds a Q1 ranking in Medicine (miscellaneous) and Q2 ranking in both Neurology and Clinical Neurology, delivers high-impact research findings and clinical insights crucial for advancing the understanding and management of multiple sclerosis. With an ISSN of 2211-0348 and an E-ISSN of 2211-0356, it provides valuable content from 2012 to 2024 aimed at researchers, healthcare professionals, and students dedicated to improving patient outcomes and fostering innovative strategies in treatment. Additionally, the journal's presence in the Scopus rankings highlights its relevance and influence in the academic community, ranking 121 out of 400 in Clinical Neurology and 59 out of 192 in Neuroscience. This comprehensive platform encourages the dissemination of cutting-edge knowledge and clinical practices, making it an essential tool for those committed to the field of neurology and related research.

Science Translational Medicine is a premier journal published by the American Association for the Advancement of Science, dedicated to bridging the gap between laboratory discovery and clinical application. With an impressive impact factor and a Q1 categorization in the field of Medicine, it is recognized as one of the leading journals, ranking 11 out of 636 in general medicine according to Scopus, placing it in the top 2% of its category. Since its inception in 2009, the journal has been at the forefront of innovative research, presenting high-quality studies that translate scientific advancements into tangible medical solutions. Researchers, professionals, and students alike will find its rich content invaluable for staying informed on cutting-edge developments in the field. The journal's commitment to accessibility ensures that the latest findings and insights are available to a global audience, fostering collaboration and scientific progress.

International Journal of Clinical and Experimental Medicine, an esteemed publication by E-CENTURY PUBLISHING CORP, serves as a vital resource for researchers and professionals in the fields of biochemistry, genetics, and molecular biology. Since its inception in 2009 and continuing until 2017, the journal has presented a wealth of knowledge aimed at fostering innovation and collaboration within the scientific community. Although the coverage has been discontinued in Scopus, the journal has established itself within the academic discourse, evidenced by its ranking in the 28th percentile for General Biochemistry, Genetics and Molecular Biology. As an open-access publication, it ensures widespread dissemination of research findings, making it a crucial platform for the advancement of clinical and experimental medicine. With its commitment to high-quality peer-reviewed articles, the International Journal of Clinical and Experimental Medicine remains a significant contribution to the body of knowledge in its field, serving as an invaluable tool for students, researchers, and practitioners alike.

Egyptian Journal of Critical Care Medicine, published by LIPPINCOTT WILLIAMS & WILKINS, serves as a vital resource in the field of critical care, providing a platform for innovative research and discussions that influence practice in intensive care settings. Established as an Open Access journal since 2013, it aims to disseminate high-quality research articles, clinical studies, and reviews that enhance understanding and application of critical care medicine. With an ISSN of 2090-7303 and an E-ISSN of 2090-9209, the journal is committed to ensuring that emerging insights and knowledge are freely available to a global audience, fostering collaboration among researchers, clinicians, and educators. Positioned within the landscape of critical care, the journal not only highlights the significance of patient management in life-threatening conditions but also promotes advancements in clinical protocols, making it essential reading for practitioners and scholars dedicated to enhancing patient outcomes in intensive care units.

SAUDI MEDICAL JOURNAL is a prominent platform in the field of medicine, dedicated to the dissemination of high-quality research and clinical findings. Published by SAUDI MED J, this journal has been an essential resource for medical professionals since its inception in 1979, aiming to bridge the gap between scientific inquiry and clinical practice. With an ISSN of 0379-5284 and an E-ISSN of 1658-3175, it ranks in the third quartile (Q3) of the Medicine (miscellaneous) category as of 2023, demonstrating its respectable influence in the medical community, reflected in its Scopus ranking of #223 out of 636 journals in General Medicine (65th percentile). While it follows a subscription-based model, the journal remains committed to advancing medical knowledge by publishing original research, reviews, and case studies relevant to both local and global health issues. The SAUDI MEDICAL JOURNAL serves as a vital resource for researchers, healthcare professionals, and students striving to enhance their understanding of emerging medical trends and practices in Saudi Arabia and beyond.

Kidney Diseases is an esteemed open-access journal published by KARGER that has been at the forefront of nephrology research since its inception in 2015. With an impressive Scopus ranking of #13 out of 81 in the field of Medicine Nephrology, placing it in the top 84th percentile, the journal has established itself as a vital resource for researchers, clinicians, and students interested in advancing knowledge on kidney health, disorders, and innovative treatment strategies. This journal aims to disseminate cutting-edge findings and clinical insights over a converged publication span from 2019 to 2024, fostering global collaboration and dialogue within the scientific community. With its commitment to open access, Kidney Diseases ensures that critical research is freely accessible, promoting wider dissemination of knowledge and the development of effective therapeutic interventions.

International Journal of Biomedicine, published by INT MEDICAL RESEARCH & DEVELOPMENT CORP, is a premier Open Access journal dedicated to advancing knowledge in the multifaceted fields of biomedicine, including but not limited to biochemistry, genetics, immunology, microbiology, and neuroscience. With its ISSN 2158-0510 and E-ISSN 2158-0529, this journal has been serving as a significant platform for researchers since its inception in 2011, ensuring the dissemination of high-quality, peer-reviewed articles. Despite currently holding a Q4 ranking in prominent categories such as Biochemistry, Genetics and Molecular Biology and Neuroscience, the journal plays a vital role in fostering scientific dialogue and innovation in these rapidly evolving domains. The journal's commitment to accessibility further empowers both seasoned professionals and budding scholars to contribute to, and benefit from, the wealth of research that characterizes the biomedicine landscape. With a significant emphasis on interdisciplinary approaches and contemporary issues, the International Journal of Biomedicine is an essential resource for those aiming to navigate the complex intersections of health, disease, and biomedical discovery.

Clinics is a distinguished, peer-reviewed journal published by Elsevier España, focusing on the expansive field of medicine. Since its establishment in 1945, and transitioning to an open access model in 2005, the journal aims to disseminate high-quality research findings that contribute to the understanding of various medical disciplines. With an impressive impact factor reflected in its Q2 categorization within the miscellaneous medicine field and ranking as #124 out of 636 in general medicine according to Scopus, Clinics is recognized for its commitment to advancing medical knowledge. Researchers, healthcare professionals, and students will find invaluable insights into contemporary medical challenges and developments through its current publications extending until 2024. The journal is headquartered in Brazil, with its administrative office located at Calle de Zurbano, 76-4th Flr Left, Madrid 28010, Spain, reinforcing its strong academic presence in the international medical community.